Incremental diagnostic value of quantitative analysis of double phase Tc-99m MIBI scintimammography for the detection of primary breast cancer additive to visual analysis

Breast Cancer Research and Treatment

Volumn 83, Issue 2, 2004, Pages 129-138

  Kim, Seong Jang ^a   Kim, In Ju ^a   Bae, Young Tae ^a   Kim, Yong Ki ^a   Kim, Dong Soo ^a  

^a Pusan National University School of Medicine   (South Korea)

Author keywords

Breast cancer; Delayed; Double phase; ROC analysis; Scintimammography; Tc 99m MIBI

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AREA UNDER THE CURVE; ARTICLE; AXILLARY LYMPH NODE; BENIGN TUMOR; BREAST CANCER; CALCULATION; CANCER DIAGNOSIS; CANCER GRADING; CLINICAL EXAMINATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; PALPATION; PATIENT CODING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; ROC CURVE; SCINTIMAMMOGRAPHY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME;

BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; PHYSICAL EXAMINATION; PREDICTIVE VALUE OF TESTS; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI;

EID: 0742269392     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BREA.0000010705.31599.89     Document Type: Article

References (35)

1. Habbema JD, van Oortmarssen GJ, van Putten DJ, Lubbe JT, van der Maas PJ: Age specific reduction in breast cancer mortality by screen: an analysis of the results of Health Insurance Plan of greater New York study. J Natl Cancer Inst 77: 317-320, 1986
2. Bird RE, Wallace TW, Yankaskas BC: Analysis of cancers missed at screening mammography. Radiology 184: 613-617, 1992
3. Kopans DB: Positive predictive value of mammography. Am J Roentgenol 158: 521-526, 1992
4. Van Dam PA, Van Goethmen MLA, Kersschot E et al.: Palpable solid breast masses: retrospective single and multimodality evaluation of 201 lesions. Radiology 166: 435-439, 1988
5. Alam MS, Kasagi K, Misaki T et al.: Diagnostic value of technetium-99m methoxyisobutylisonitrile scintigraphy in detecting thyroid cancer metastases: a critical evaluation. Thyroid 8: 1091-1100, 1998
6. Baillet G, Albuquerque L, Chen Q, Poisson M, Delattre JY: Evaluation of single-photon emission tomography imaging of supratentorial brain gliomas with technetium-99m sestamibi. Eur J Nucl Med 21: 1061-1066, 1994
7. Kao CH, Wang SJ, Chen CY, Yeh SH: Detection of esophageal carcinoma using Tc-99m MIBI SPECT imaging. Clin Nucl Med 19: 1069-1074, 1994
8. Bom HS, Kim YC, Song HC, Min JJ, Kim JY, Park KO: Technetium-99m-MIBI uptake in small cell lung cancer. J Nucl Med 39: 91-94, 1998
9. Moka D, Voth E, Dietlein M, Larena Avellaneda A, Schicha H: Technetium 99m-MIBI-SPECT: a highly sensitive diagnostic tool for localization of parathyroid adenomas. Surgery 128: 29-35, 1998
10. Kim SJ, Seok JW, Kim IJ, Kim YK: Tc-99m MIBI scintigraphy in a patient with primary and metastatic malignant melanoma. Clin Nucl Med 27: 351-353, 2002
11. Kim SJ, Kim JJ, Kim YK: Tc-99m MIBI, Tc-99m tetrofosmin, and Tc-99m (V) DMSA accumulation in recurrent malignant thymoma. Clin Nucl Med 27: 30-33, 2002
12. Kim SJ, Kim IJ, Bae YT, Kim YK: Technetium-99m tetrofosmin scintimammography in suspected breast cancer patients: a comparison with technetium-99m MIBI. Med Princ Prac 9: 282-289, 2000
13. Taillefer R, Robidoux A, Lambert R, Turpin S, Laperriere J: Technetium-99m sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med 36: 1758-1765, 1995
14. 99mTc-MIBI mammoscintigraphy in the diagnosis of breast cancer. Orv Hetil 139: 183-187, 1998
15. 99mTc-MIBI prone scintimammography in patients with suspicious breast cancer: relationship with mammography and tumor size. Int J Oncol 12: 661-664, 1998
16. Khalkhali I, Mena I, Jounnane E et al.: Prone scintimammography in patients with suspicion of carcinoma of breast. J Am Coll Surg 178: 491-497, 1994
17. Kim SJ, Kim IJ, Kim YK, Bae YT: Tc-99m MIBI scintimammography in suspected breast cancer patients: unicenter trial. J Nucl Med 41(Suppl): 144P (abstract) 2000
18. 99mTc-MIBI scintimammography: receiver operating characteristic curve analysis. J Nucl Med 42(Suppl): 25P (abstract) 2001
19. Greenlee RT, Murray T, Bolden S, Wingo PA: Cancer Statistics, 2000. CA Cancer J Clin 50: 7-33, 2000
20. 99mTc-MIBI in imaging breast cancer. Seminars in Nucl Med 27: 40-54, 1997
21. Lu G, Shih WJ, Huang HY et al.: Tc-99m MIBI mammoscintigraphy of breast masses: early and delayed imaging. Nucl Med Commun 16: 150-156, 1995
22. 99mTc- sestamibi scintimammography and trans-scan in diagnosing breast cancer. J Nucl Med 40: 376-380, 1999
23. Arslan N, Ozturk E, Ilgan S et al.: The comparison of dual phase Tc-99m MIBI and Tc-99m MDP scintimammography in the evaluation of breast masses: preliminary report. Ann Nucl Med 14: 39-46, 2000
24. 99mTc-sestamibi scintimammography in the diagnosis of breast cancer. Nucl Med Commun 21: 341-348, 2000
25. Ambrus E, Rajtar M, Omandi K et al.: Value of Tc-99m MIBI and Tc-99m (V) DMSA scintigraphy in evaluation of breast mass lesions. Antican Res 17: 1599-1605, 1997
26. Danielsson R, Bone B, Gad A, Sylvan A, Aspelin P: Sensitivity and specificity of planar scintimammography with 99mTc-sestamibi. Acta Radiologica 40: 394-399, 1999
27. Palmedo H, Schomburg A, Grunwald F, Mallmann P, Boldt I, Biersack HJ: Technetium-99m MIBI scintimammography for suspicious breast lesions. J Nucl Med 37: 626-630.24, 1996
28. Scopinaro F, Schillaci O, Ussof W et al.: A three center study on the diagnostic accuracy of Tc-99m MIBI scintimammography. Antican Res 17: 1631-1634, 1997
29. Tofani A, Sciuto R, Semprebene A et al.: Tc-99m MIBI scintimammography in 300 consecutive patients: factors that may affect accuracy. Nucl Med Commun 20: 1113-1121, 1999
30. 99mTc-MIBI breast imaging: multicenter trial results. J Nucl Med 41: 1973-1979, 2000
31. 99mTc- MIBI scintimammography. Ann Nucl Med 12: 307-312, 1998
32. Maini C, Tofani A, Sciuto R et al.: Technetium-99m MIBI scintigraphy in the assessment of neoadjuvant chemotherapy in breast carcinoma. J Nucl Med 38: 1546-1551, 1997
33. Yoon JH, Bom HS, Song HC, Lee JH, Jaegal YJ: Double-phase Tc-99m sestamibi scintimammography to assess angiogenesis and p-glycoprotein expression in patients with untreated breast cancer. Clin Nucl Med 24: 314-318, 1999
34. Scopinaro F, Schillaci O, Scarpini M et al.: Technetium-99m sestamibi: an indicator of breast cancer invasiveness. Eur J Nucl Med 21: 984-987, 1994
35. 99mTc- MIBI scintimammographical quantitative indices for predicting local recurrence of breast cancer. J Nucl Med 5(Suppl): 288P (abstract) 2000